id stringlengths 11 11 | tags stringlengths 10 777 | text stringlengths 2 1.5k | dataset_num int64 1 3 | tokens list | ner_tags list |
|---|---|---|---|---|---|
NCT01703117 | 34:54:chronic_disease,84:105:chronic_disease,141:164:treatment,166:181:chronic_disease,202:226:chronic_disease, | Any unstable serious co-existing medical condition(s) including but not limited to myocardial infarction, coronary artery disease requiring coronary bypass surgery, unstable angina, clinically evident congestive heart failure within 6 months prior to the screening visit | 3 | [
"Any",
"unstable",
"serious",
"co-existing",
"medical",
"condition",
"(",
"s",
")",
"including",
"but",
"not",
"limited",
"to",
"myocardial",
"infarction",
",",
"coronary",
"artery",
"disease",
"requiring",
"coronary",
"bypass",
"surgery",
",",
"unstable",
"angina... | [
0,
2,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02012296 | 57:70:chronic_disease | Inability to swallow capsules or known gastrointestinal malabsorption | 3 | [
"Inability",
"to",
"swallow",
"capsules",
"or",
"known",
"gastrointestinal",
"malabsorption"
] | [
0,
0,
0,
0,
0,
0,
0,
2
] |
NCT02143050 | 27:36:allergy_name | Known hypersensitivity to Metformin or any of its components | 3 | [
"Known",
"hypersensitivity",
"to",
"Metformin",
"or",
"any",
"of",
"its",
"components"
] | [
0,
0,
0,
4,
0,
0,
0,
0,
0
] |
NCT01896921 | 20:25:treatment,124:135:treatment,139:148:treatment | Concomitant use of drugs known to impact or be impacted in terms of pharmacokinetics or drug-drug interactions with either raltegravir or maraviroc | 3 | [
"Concomitant",
"use",
"of",
"drugs",
"known",
"to",
"impact",
"or",
"be",
"impacted",
"in",
"terms",
"of",
"pharmacokinetics",
"or",
"drug-drug",
"interactions",
"with",
"either",
"raltegravir",
"or",
"maraviroc"
] | [
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1
] |
NCT02019940 | ,,50:58:chronic_disease,,,281:305:treatment,317:326:treatment,330:334:chronic_disease,,398:413:treatment,430:446:treatment | For participants over the age of 60, evidence of dementia as determined by the St. Luis University Mental Status Exam (SLUMS; participants with total scores less than or equal to 20 will be excluded and referred to their Primary Care Physician for follow-up/dementia evaluation); Structured psychotherapy focused on trea... | 3 | [
"For",
"participants",
"over",
"the",
"age",
"of",
"60",
",",
"evidence",
"of",
"dementia",
"as",
"determined",
"by",
"the",
"St.",
"Luis",
"University",
"Mental",
"Status",
"Exam",
"(",
"SLUMS",
";",
"participants",
"with",
"total",
"scores",
"less",
"than"... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
1,
1,
2,
0,
0,
0,
0,
0,
0,
0,
0... |
NCT02592551 | 14:23:treatment,31:34:treatment,38:53:treatment,65:73:treatment | Any previous treatment with a PD1 or PD-L1 inhibitor, including MEDI4736 | 3 | [
"Any",
"previous",
"treatment",
"with",
"a",
"PD1",
"or",
"PD-L1",
"inhibitor",
",",
"including",
"MEDI4736"
] | [
0,
0,
1,
0,
0,
1,
0,
1,
1,
0,
0,
1
] |
NCT02389465 | 1:20:chronic_disease | Renal insufficiency | 3 | [
"Renal",
"insufficiency"
] | [
2,
2
] |
NCT02310633 | 14:21:chronic_disease | no receptive aphasia (impairing ability to comprehend task instructions) | 3 | [
"no",
"receptive",
"aphasia",
"(",
"impairing",
"ability",
"to",
"comprehend",
"task",
"instructions",
")"
] | [
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01996865 | 26:64:cancer,66:88:cancer,93:113:cancer | Histologically confirmed Follicular Lymphoma (Grade 1, 2 or 3a), Marginal Zone Lymphoma, or Mantle Cell Lymphoma | 3 | [
"Histologically",
"confirmed",
"Follicular",
"Lymphoma",
"(",
"Grade",
"1",
",",
"2",
"or",
"3a",
")",
",",
"Marginal",
"Zone",
"Lymphoma",
",",
"or",
"Mantle",
"Cell",
"Lymphoma"
] | [
0,
0,
3,
3,
3,
3,
3,
3,
3,
0,
0,
0,
0,
3,
3,
3,
0,
0,
3,
3,
3
] |
NCT01365169 | 1:14:treatment, | Major surgery in the past 8 weeks (Arms 1 and 4) | 3 | [
"Major",
"surgery",
"in",
"the",
"past",
"8",
"weeks",
"(",
"Arms",
"1",
"and",
"4",
")"
] | [
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02860000 | ,,,139:149:treatment, | Receipt of corticosteroids =< 7 days prior to registration, unless patient has been taking a continuous dose of no more than 15 mg/day of prednisone for at least 30 days prior to registration | 3 | [
"Receipt",
"of",
"corticosteroids",
"=",
"<",
"7",
"days",
"prior",
"to",
"registration",
",",
"unless",
"patient",
"has",
"been",
"taking",
"a",
"continuous",
"dose",
"of",
"no",
"more",
"than",
"15",
"mg/day",
"of",
"prednisone",
"for",
"at",
"least",
"3... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02169089 | 15:31:chronic_disease,,,59:80:treatment,98:102:treatment,110:128:treatment,130:135:treatment,136:143:treatment | Patients with Type II Diabetes with HbA1c ≤ 9.0 on stable anti-glycemic regimen that may include oral and/or injectable therapy (GLP-1/Insulin etc.) | 3 | [
"Patients",
"with",
"Type",
"II",
"Diabetes",
"with",
"HbA1c",
"≤",
"9.0",
"on",
"stable",
"anti-glycemic",
"regimen",
"that",
"may",
"include",
"oral",
"and/or",
"injectable",
"therapy",
"(",
"GLP-1/Insulin",
"etc",
".",
")"
] | [
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
1,
0,
1,
1,
0,
1,
0,
0,
0
] |
NCT02429934 | ,,,,163:173:treatment | Women of child bearing potential unwilling or unable to use an acceptable method to avoid pregnancy for the entire study period and for up to 2 months after last study drug | 3 | [
"Women",
"of",
"child",
"bearing",
"potential",
"unwilling",
"or",
"unable",
"to",
"use",
"an",
"acceptable",
"method",
"to",
"avoid",
"pregnancy",
"for",
"the",
"entire",
"study",
"period",
"and",
"for",
"up",
"to",
"2",
"months",
"after",
"last",
"study",
... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02816736 | 1:17:chronic_disease | Active infection | 3 | [
"Active",
"infection"
] | [
2,
2
] |
NCT02310464 | 1:23:treatment | Chemotherapeutic Agent | 3 | [
"Chemotherapeutic",
"Agent"
] | [
1,
1
] |
NCT01807897 | 21:43:chronic_disease, | Hospitalization for acute decompensated HF within previous 30 days | 3 | [
"Hospitalization",
"for",
"acute",
"decompensated",
"HF",
"within",
"previous",
"30",
"days"
] | [
0,
0,
2,
2,
2,
0,
0,
0,
0
] |
NCT02324387 | 9:47:cancer | without metastasis (M0) invasive breast cancer | 3 | [
"without",
"metastasis",
"(",
"M0",
")",
"invasive",
"breast",
"cancer"
] | [
0,
3,
3,
3,
3,
3,
0,
0
] |
NCT01187368 | 1:35:chronic_disease | irreversible cognitive dysfunction | 3 | [
"irreversible",
"cognitive",
"dysfunction"
] | [
2,
2,
2
] |
NCT02914509 | 55:65:allergy_name,73:86:allergy_name,88:99:allergy_name | Known or suspected allergy and/or hypersensitivity to travoprost or any prostaglandin, fluorescein, or to any component of the study products | 3 | [
"Known",
"or",
"suspected",
"allergy",
"and/or",
"hypersensitivity",
"to",
"travoprost",
"or",
"any",
"prostaglandin",
",",
"fluorescein",
",",
"or",
"to",
"any",
"component",
"of",
"the",
"study",
"products"
] | [
0,
0,
0,
0,
0,
0,
0,
4,
0,
0,
4,
0,
4,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02073097 | ,45:75:treatment,83:106:treatment,115:121:treatment,174:189:cancer,272:274:treatment,282:294:treatment,296:310:treatment,315:333:treatment,335:344:treatment, | Patients may have received brief (<15 days) treatment with glucocorticoids and/or 1 cycle of chemotherapy such as R-CHOP [or some component(s) thereof] for the diagnosis of B-cell lymphoma provided they had all necessary staging tests performed prior to R-CHOP including CT and/or PET/CT scans, echocardiogram and bone m... | 3 | [
"Patients",
"may",
"have",
"received",
"brief",
"(",
"<",
"15",
"days",
")",
"treatment",
"with",
"glucocorticoids",
"and/or",
"1",
"cycle",
"of",
"chemotherapy",
"such",
"as",
"R-CHOP",
"[",
"or",
"some",
"component",
"(",
"s",
")",
"thereof",
"]",
"for",... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
1,
1,
1,
1,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
1,
0,
1,
0,
1,
1,
1,
0,
1,
0,
0,
0,
0... |
NCT02394535 | 24:36:cancer, | patients with previous malignancies but without evidence of disease for 3 years will be allowed to enter the trial | 3 | [
"patients",
"with",
"previous",
"malignancies",
"but",
"without",
"evidence",
"of",
"disease",
"for",
"3",
"years",
"will",
"be",
"allowed",
"to",
"enter",
"the",
"trial"
] | [
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03036254 | 1:14:chronic_disease | Brain disease that affects cognition | 3 | [
"Brain",
"disease",
"that",
"affects",
"cognition"
] | [
2,
2,
0,
0,
0
] |
NCT02466685 | 1:32:treatment, | Antidepressant (AD) medications are allowed if the subject has been treated with a stable dose for at least 2 months before screening | 3 | [
"Antidepressant",
"(",
"AD",
")",
"medications",
"are",
"allowed",
"if",
"the",
"subject",
"has",
"been",
"treated",
"with",
"a",
"stable",
"dose",
"for",
"at",
"least",
"2",
"months",
"before",
"screening"
] | [
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02533674 | 22:33:treatment | Prior treatment with oxaliplatin | 3 | [
"Prior",
"treatment",
"with",
"oxaliplatin"
] | [
0,
0,
0,
1
] |
NCT02914561 | 26:28:chronic_disease,37:59:chronic_disease,61:88:chronic_disease,90:98:chronic_disease,100:120:chronic_disease | Current complications of CD such as symptomatic strictures, severe rectal/anal stenosis, fistulae, short bowel syndrome, etc | 3 | [
"Current",
"complications",
"of",
"CD",
"such",
"as",
"symptomatic",
"strictures",
",",
"severe",
"rectal/anal",
"stenosis",
",",
"fistulae",
",",
"short",
"bowel",
"syndrome",
",",
"etc"
] | [
0,
0,
0,
2,
0,
0,
2,
2,
0,
2,
2,
2,
0,
2,
0,
2,
2,
2,
0,
0
] |
NCT01913106 | 1:17:cancer | cutaneous cancer | 3 | [
"cutaneous",
"cancer"
] | [
3,
3
] |
NCT02420977 | 1:28:treatment | Hormone deprivation therapy | 3 | [
"Hormone",
"deprivation",
"therapy"
] | [
1,
1,
1
] |
NCT02338999 | 19:32:treatment | Expected need for major surgery during trial | 3 | [
"Expected",
"need",
"for",
"major",
"surgery",
"during",
"trial"
] | [
0,
0,
0,
1,
1,
0,
0
] |
NCT02866279 | 1:9:chronic_disease | Diabetes (gestational or pre-gestational) | 3 | [
"Diabetes",
"(",
"gestational",
"or",
"pre-gestational",
")"
] | [
2,
0,
0,
0,
0,
0
] |
NCT02139280 | 32:48:allergy_name | Documented hypersensitivity to any of the drugs used in the protocol | 3 | [
"Documented",
"hypersensitivity",
"to",
"any",
"of",
"the",
"drugs",
"used",
"in",
"the",
"protocol"
] | [
0,
0,
0,
4,
4,
4,
4,
0,
0,
0,
0
] |
NCT02570984 | ,24:43:treatment, | More than four days of albuterol treatment (for symptoms) in the past two weeks | 3 | [
"More",
"than",
"four",
"days",
"of",
"albuterol",
"treatment",
"(",
"for",
"symptoms",
")",
"in",
"the",
"past",
"two",
"weeks"
] | [
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02234193 | 40:55:chronic_disease,64:72:chronic_disease,74:83:chronic_disease,85:97:chronic_disease | Subjects with uncontrolled or unstable chronic disease such as diabetes, hepatitis, hypertension, etc | 3 | [
"Subjects",
"with",
"uncontrolled",
"or",
"unstable",
"chronic",
"disease",
"such",
"as",
"diabetes",
",",
"hepatitis",
",",
"hypertension",
",",
"etc"
] | [
0,
0,
0,
0,
0,
2,
2,
0,
0,
2,
0,
2,
0,
2,
0,
0
] |
NCT02488967 | 10:17:treatment,23:37:treatment,41:48:treatment,57:67:cancer | Previous therapy with anthracyclines or taxanes for any malignancy | 3 | [
"Previous",
"therapy",
"with",
"anthracyclines",
"or",
"taxanes",
"for",
"any",
"malignancy"
] | [
0,
1,
0,
1,
0,
1,
0,
0,
3
] |
NCT02468453 | 8:45:treatment,47:53:treatment,61:88:treatment,,121:138:treatment | Use of non-steroidal anti-inflammatory drugs (NSAIDS, e.g., ibuprofen-containing agents) one week before and after each treatment session | 3 | [
"Use",
"of",
"non-steroidal",
"anti-inflammatory",
"drugs",
"(",
"NSAIDS",
",",
"e.g.",
",",
"ibuprofen-containing",
"agents",
")",
"one",
"week",
"before",
"and",
"after",
"each",
"treatment",
"session"
] | [
0,
0,
1,
1,
1,
0,
1,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02250534 | 1:16:chronic_disease, | Suicide attempt in past 6 months | 3 | [
"Suicide",
"attempt",
"in",
"past",
"6",
"months"
] | [
2,
2,
0,
0,
0,
0
] |
NCT03112863 | 60:87:chronic_disease | Those with acne, eczema, seborrheic dermatitis, rosacea or polycystic ovarian syndrome | 3 | [
"Those",
"with",
"acne",
",",
"eczema",
",",
"seborrheic",
"dermatitis",
",",
"rosacea",
"or",
"polycystic",
"ovarian",
"syndrome"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2
] |
NCT02465060 | 5:27:treatment, | any concomitant medication known to prolong the QT interval | 3 | [
"any",
"concomitant",
"medication",
"known",
"to",
"prolong",
"the",
"QT",
"interval"
] | [
0,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT01858168 | 21:44:chronic_disease | Subjects with known active hepatitis B or C | 3 | [
"Subjects",
"with",
"known",
"active",
"hepatitis",
"B",
"or",
"C"
] | [
0,
0,
0,
2,
2,
2,
2,
2
] |
NCT02101736 | 36:60:chronic_disease | Clinical or molecular diagnosis of Neurofibromatosis Type 1 | 3 | [
"Clinical",
"or",
"molecular",
"diagnosis",
"of",
"Neurofibromatosis",
"Type",
"1"
] | [
0,
0,
0,
0,
0,
2,
2,
2
] |
NCT01505569 | 8:23:cancer | Infant Medulloblastoma | 3 | [
"Infant",
"Medulloblastoma"
] | [
0,
3
] |
NCT02433626 | 9:35:cancer,37:42:cancer,44:54:cancer,56:60:cancer,62:79:cancer,90:96:cancer | Part 3: Gynecological malignancies, HNSCC, colorectal, lung, pancreatic cancer, or other tumors with Sponsor approval | 3 | [
"Part",
"3",
":",
"Gynecological",
"malignancies",
",",
"HNSCC",
",",
"colorectal",
",",
"lung",
",",
"pancreatic",
"cancer",
",",
"or",
"other",
"tumors",
"with",
"Sponsor",
"approval"
] | [
0,
0,
0,
3,
3,
0,
3,
0,
3,
0,
3,
0,
3,
3,
0,
0,
0,
3,
0,
0,
0
] |
NCT00209235 | ,,107:109:treatment | the patient must be over 3 years of age (ie., after 3rd birthday) AND also be pre-pubertal at the time of GH initiation | 3 | [
"the",
"patient",
"must",
"be",
"over",
"3",
"years",
"of",
"age",
"(",
"ie.",
",",
"after",
"3rd",
"birthday",
")",
"AND",
"also",
"be",
"pre-pubertal",
"at",
"the",
"time",
"of",
"GH",
"initiation"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT02008656 | 64:67:treatment | Clinical Stage II (T3-4, N-) or Stage III (any T, N+) based on MRI | 3 | [
"Clinical",
"Stage",
"II",
"(",
"T3-4",
",",
"N-",
")",
"or",
"Stage",
"III",
"(",
"any",
"T",
",",
"N+",
")",
"based",
"on",
"MRI"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01130077 | 22:30:treatment,32:40:treatment,42:51:treatment | Growth factors (e.g. Procrit®, Aranesp®, Neulasta®) | 3 | [
"Growth",
"factors",
"(",
"e.g",
".",
"Procrit®",
",",
"Aranesp®",
",",
"Neulasta®",
")"
] | [
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1
] |
NCT02080221 | 1:22:chronic_disease | Uncontrolled diabetes | 3 | [
"Uncontrolled",
"diabetes"
] | [
2,
2
] |
NCT01042522 | 36:48:chronic_disease | No signs of clinically significant hearing loss | 3 | [
"No",
"signs",
"of",
"clinically",
"significant",
"hearing",
"loss"
] | [
0,
0,
0,
0,
0,
2,
2
] |
NCT00887146 | 74:95:treatment | Concomitant serious immunocompromised status (other than that related to concomitant steroids) that would compromise the safety of the patient on the study | 3 | [
"Concomitant",
"serious",
"immunocompromised",
"status",
"(",
"other",
"than",
"that",
"related",
"to",
"concomitant",
"steroids",
")",
"that",
"would",
"compromise",
"the",
"safety",
"of",
"the",
"patient",
"on",
"the",
"study"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01773694 | 20:44:treatment | patients receiving prophylactic antibiotics | 3 | [
"patients",
"receiving",
"prophylactic",
"antibiotics"
] | [
0,
0,
1,
1
] |
NCT02966665 | 1:12:chronic_disease, | Severe COPD (use of supplemental oxygen, or have a one-second forced expiratory volume of less than 30% predicted) | 3 | [
"Severe",
"COPD",
"(",
"use",
"of",
"supplemental",
"oxygen",
",",
"or",
"have",
"a",
"one-second",
"forced",
"expiratory",
"volume",
"of",
"less",
"than",
"30",
"%",
"predicted",
")"
] | [
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01614197 | 1:16:treatment,37:52:treatment,37:51:treatment, | Corticosteroids: Patients receiving corticosteroids who have not been on a stable or decreasing dose of corticosteroid for at least 7 days prior to enrollment are not eligible | 3 | [
"Corticosteroids",
":",
"Patients",
"receiving",
"corticosteroids",
"who",
"have",
"not",
"been",
"on",
"a",
"stable",
"or",
"decreasing",
"dose",
"of",
"corticosteroid",
"for",
"at",
"least",
"7",
"days",
"prior",
"to",
"enrollment",
"are",
"not",
"eligible"
] | [
1,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02864147 | 43:52:allergy_name | Patients with a known hypersensitivity to imiquimod | 3 | [
"Patients",
"with",
"a",
"known",
"hypersensitivity",
"to",
"imiquimod"
] | [
0,
0,
0,
0,
0,
0,
4
] |
NCT02448498 | 14:38:chronic_disease | Diagnosis of Type 2 Diabetes Mellitus | 3 | [
"Diagnosis",
"of",
"Type",
"2",
"Diabetes",
"Mellitus"
] | [
0,
0,
2,
2,
2,
2
] |
NCT03013543 | 33:43:allergy_name | Significant hypersensitivity to study drug | 3 | [
"Significant",
"hypersensitivity",
"to",
"study",
"drug"
] | [
0,
0,
0,
4,
4
] |
NCT02592551 | 40:52:treatment | No tissue is obtainable at the time of thoracoscopy | 3 | [
"No",
"tissue",
"is",
"obtainable",
"at",
"the",
"time",
"of",
"thoracoscopy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01992861 | 31:34:treatment,, | for the test-retest sub-study MRI, patients must have a GFR of > 60 mL/min/1.73m^2 | 3 | [
"for",
"the",
"test-retest",
"sub-study",
"MRI",
",",
"patients",
"must",
"have",
"a",
"GFR",
"of",
">",
"60",
"mL/min/1.73m^2"
] | [
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02916524 | 16:30:chronic_disease,49:59:chronic_disease,60:82:chronic_disease,117:124:chronic_disease | Diagnosed with mental illness other than active depression Neurological condition other than that which resulted in aphasia | 3 | [
"Diagnosed",
"with",
"mental",
"illness",
"other",
"than",
"active",
"depression",
"Neurological",
"condition",
"other",
"than",
"that",
"which",
"resulted",
"in",
"aphasia"
] | [
0,
0,
2,
2,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
2
] |
NCT02402088 | ,,,78:92:treatment | Women on oral contraceptives, peri and post menopausal women, and those with hysterectomies | 3 | [
"Women",
"on",
"oral",
"contraceptives",
",",
"peri",
"and",
"post",
"menopausal",
"women",
",",
"and",
"those",
"with",
"hysterectomies"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02910700 | 23:35:treatment,39:51:treatment,80:92:treatment,96:107:treatment | Patients who have had chemotherapy or radiotherapy within 4 weeks (6 weeks for nitrosoureas or mitomycin C) prior to entering the study or those who have not recovered from adverse events due to agents administered more than 4 weeks earlier | 3 | [
"Patients",
"who",
"have",
"had",
"chemotherapy",
"or",
"radiotherapy",
"within",
"4",
"weeks",
"(",
"6",
"weeks",
"for",
"nitrosoureas",
"or",
"mitomycin",
"C",
")",
"prior",
"to",
"entering",
"the",
"study",
"or",
"those",
"who",
"have",
"not",
"recovered"... | [
0,
0,
0,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01050855 | 1:20:chronic_disease | Sickle cell disease | 3 | [
"Sickle",
"cell",
"disease"
] | [
2,
2,
2
] |
NCT02110992 | 1:29:cancer | non-melanomatous skin cancer | 3 | [
"non-melanomatous",
"skin",
"cancer"
] | [
3,
3,
3
] |
NCT02680535 | 8:23:treatment | If the standard biopsy cores are positive, they must be from the same location in the prostate as MR lesion was biopsied and proven to be cancerous | 3 | [
"If",
"the",
"standard",
"biopsy",
"cores",
"are",
"positive",
",",
"they",
"must",
"be",
"from",
"the",
"same",
"location",
"in",
"the",
"prostate",
"as",
"MR",
"lesion",
"was",
"biopsied",
"and",
"proven",
"to",
"be",
"cancerous"
] | [
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01950351 | ,22:37:treatment | within 10 days after prostate biopsy | 3 | [
"within",
"10",
"days",
"after",
"prostate",
"biopsy"
] | [
0,
0,
0,
0,
1,
1
] |
NCT02463305 | 1:13:treatment | appendectomy | 3 | [
"appendectomy"
] | [
1
] |
NCT02351544 | 15:24:chronic_disease,45:66:chronic_disease | Patients with migraines related to inferior turbinate hypertrophy or septal deviation | 3 | [
"Patients",
"with",
"migraines",
"related",
"to",
"inferior",
"turbinate",
"hypertrophy",
"or",
"septal",
"deviation"
] | [
0,
0,
2,
0,
0,
0,
2,
2,
0,
0,
0
] |
NCT02261519 | 1:26:treatment, | Electroconvulsive Therapy within 6 months prior to screening | 3 | [
"Electroconvulsive",
"Therapy",
"within",
"6",
"months",
"prior",
"to",
"screening"
] | [
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT02343549 | 1:20:treatment | Implanted pacemaker | 3 | [
"Implanted",
"pacemaker"
] | [
1,
1
] |
NCT02037048 | 15:21:chronic_disease,, | Patients with angina, a cardiac ejection fraction < 50% | 3 | [
"Patients",
"with",
"angina",
",",
"a",
"cardiac",
"ejection",
"fraction",
"<",
"50",
"%"
] | [
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02584647 | 23:35:treatment,39:51:treatment,,80:92:treatment,96:107:treatment | Patients who have had chemotherapy or radiotherapy within 4 weeks (6 weeks for nitrosoureas or mitomycin C) prior to entering the study or those who have not recovered from adverse events due to agents administered more than 4 weeks earlier | 3 | [
"Patients",
"who",
"have",
"had",
"chemotherapy",
"or",
"radiotherapy",
"within",
"4",
"weeks",
"(",
"6",
"weeks",
"for",
"nitrosoureas",
"or",
"mitomycin",
"C",
")",
"prior",
"to",
"entering",
"the",
"study",
"or",
"those",
"who",
"have",
"not",
"recovered"... | [
0,
0,
0,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02128906 | 1:4:chronic_disease,45:68:treatment,140:151:treatment | HIV-positive patients receiving combination anti-retroviral therapy are excluded from the study because of possible drug interactions with study drugs | 3 | [
"HIV-positive",
"patients",
"receiving",
"combination",
"anti-retroviral",
"therapy",
"are",
"excluded",
"from",
"the",
"study",
"because",
"of",
"possible",
"drug",
"interactions",
"with",
"study",
"drugs"
] | [
2,
0,
0,
0,
1,
1,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02520791 | ,91:103:chronic_disease,112:133:chronic_disease,137:156:chronic_disease,166:185:chronic_disease,187:206:chronic_disease,208:225:chronic_disease | Any history or evidence of opportunistic infection within 6 months of screening including tuberculosis, severe cytomegalovirus (CMV) or herpetic infections (such as disseminated herpes, herpes encephalitis, ophthalmic herpes) | 3 | [
"Any",
"history",
"or",
"evidence",
"of",
"opportunistic",
"infection",
"within",
"6",
"months",
"of",
"screening",
"including",
"tuberculosis",
",",
"severe",
"cytomegalovirus",
"(",
"CMV",
")",
"or",
"herpetic",
"infections",
"(",
"such",
"as",
"disseminated",
... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
2,
2,
0,
0,
0,
2,
2,
0,
0,
0,
2,
2,
2,
0,
0,
0,
2,
2,
0
] |
NCT02579174 | 41:60:chronic_disease | Radiographically confirmed diagnosis of osteoarthritis (OA) | 3 | [
"Radiographically",
"confirmed",
"diagnosis",
"of",
"osteoarthritis",
"(",
"OA",
")"
] | [
0,
0,
0,
0,
2,
2,
0,
0
] |
NCT02299414 | 1:23:chronic_disease,,,,,, | Chronic kidney disease - including baseline proteinuria (>300mg/24-hr, p/c ratio >0.3, or persistent 1+ proteinuria*) or creatinine >1.2 | 3 | [
"Chronic",
"kidney",
"disease",
"-",
"including",
"baseline",
"proteinuria",
"(",
">",
"300mg/24-hr",
",",
"p/c",
"ratio",
">",
"0.3",
",",
"or",
"persistent",
"1+",
"proteinuria",
"*",
")",
"or",
"creatinine",
">",
"1.2"
] | [
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02043548 | 20:32:treatment | 4 week washout for methotrexate | 3 | [
"4",
"week",
"washout",
"for",
"methotrexate"
] | [
0,
0,
0,
0,
1
] |
NCT01849146 | 17:31:treatment | able to swallow whole capsules | 3 | [
"able",
"to",
"swallow",
"whole",
"capsules"
] | [
0,
0,
0,
1,
1
] |
NCT02402907 | 12:25:allergy_name | allergy to chlorhexidine | 3 | [
"allergy",
"to",
"chlorhexidine"
] | [
0,
0,
4
] |
NCT01614197 | 1:14:treatment,,69:82:treatment,89:103:treatment,108:155:treatment | Immunotherapy: At least 30 days after the completion of any type of immunotherapy, e.g. tumor vaccines. or chimeric antigen receptor T cell (CART) therapy or tumor vaccines | 3 | [
"Immunotherapy",
":",
"At",
"least",
"30",
"days",
"after",
"the",
"completion",
"of",
"any",
"type",
"of",
"immunotherapy",
",",
"e.g",
".",
"tumor",
"vaccines",
".",
"or",
"chimeric",
"antigen",
"receptor",
"T",
"cell",
"(",
"CART",
")",
"therapy",
"or",... | [
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
1,
1,
0,
0,
1,
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0
] |
NCT01794793 | ,,109:120:treatment, | Sexually active males, unless they use a condom during intercourse while taking drug and for 1 months after pasireotide s.c. last dose and 3 months after pasireotide LAR last dose | 3 | [
"Sexually",
"active",
"males",
",",
"unless",
"they",
"use",
"a",
"condom",
"during",
"intercourse",
"while",
"taking",
"drug",
"and",
"for",
"1",
"months",
"after",
"pasireotide",
"s.c.",
"last",
"dose",
"and",
"3",
"months",
"after",
"pasireotide",
"LAR",
... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01993719 | 12:36:treatment | Concurrent systemic steroid therapy | 3 | [
"Concurrent",
"systemic",
"steroid",
"therapy"
] | [
0,
1,
1,
1
] |
NCT02608840 | 12:19:chronic_disease,12:20:chronic_disease,31:42:treatment | history of seizures or taking medications that may lower the seizure threshold | 3 | [
"history",
"of",
"seizures",
"or",
"taking",
"medications",
"that",
"may",
"lower",
"the",
"seizure",
"threshold"
] | [
0,
0,
2,
0,
0,
1,
0,
0,
0,
0,
2,
0
] |
NCT02719327 | 1:18:chronic_disease | diabetes mellitus | 3 | [
"diabetes",
"mellitus"
] | [
2,
2
] |
NCT02301117 | 9:50:chronic_disease | Certain serious illnesses or medical condition(s) | 3 | [
"Certain",
"serious",
"illnesses",
"or",
"medical",
"condition",
"(",
"s",
")"
] | [
0,
2,
2,
2,
2,
2,
0,
0,
0
] |
NCT02237183 | 54:66:treatment | Participants must have the ability to safely undergo bronchoscopy in the judgment of the investigators | 3 | [
"Participants",
"must",
"have",
"the",
"ability",
"to",
"safely",
"undergo",
"bronchoscopy",
"in",
"the",
"judgment",
"of",
"the",
"investigators"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT02583789 | 25:53:treatment,55:65:treatment,67:76:treatment,80:90:treatment,93:115:treatment,117:145:treatment,150:174:treatment, | Patients on stable dose phosphodiesterase inhibitors (sildenafil, tadalafil or vardenafil), endothelin antagonists, alpha adrenergic antagonists, or calcium channel blockers defined as 3-months with no change in dose | 3 | [
"Patients",
"on",
"stable",
"dose",
"phosphodiesterase",
"inhibitors",
"(",
"sildenafil",
",",
"tadalafil",
"or",
"vardenafil",
")",
",",
"endothelin",
"antagonists",
",",
"alpha",
"adrenergic",
"antagonists",
",",
"or",
"calcium",
"channel",
"blockers",
"defined",
... | [
0,
0,
0,
0,
1,
1,
0,
1,
0,
1,
0,
1,
0,
0,
1,
1,
0,
1,
1,
1,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03126370 | 60:70:allergy_name,71:81:allergy_name,85:98:allergy_name,99:120:allergy_name | Medications that may cause unwanted drug interactions with ledipasvir/sofosbuvir or emtricitabine/tenofovir alafenamide | 3 | [
"Medications",
"that",
"may",
"cause",
"unwanted",
"drug",
"interactions",
"with",
"ledipasvir/sofosbuvir",
"or",
"emtricitabine/tenofovir",
"alafenamide"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
4,
0,
4,
4
] |
NCT02392286 | 14:21:chronic_disease | Diagnosis of Crohn's flare | 3 | [
"Diagnosis",
"of",
"Crohn",
"'s",
"flare"
] | [
2,
2,
2,
2,
2
] |
NCT02721537 | 12:35:chronic_disease | History of post-traumatic seizures | 3 | [
"History",
"of",
"post-traumatic",
"seizures"
] | [
0,
0,
2,
2
] |
NCT01904136 | 7:16:chronic_disease | Liver cirrhosis | 3 | [
"Liver",
"cirrhosis"
] | [
0,
2
] |
NCT03022292 | 44:72:treatment | The study eye is treatment naive regarding treatment of neovascular AMD | 3 | [
"The",
"study",
"eye",
"is",
"treatment",
"naive",
"regarding",
"treatment",
"of",
"neovascular",
"AMD"
] | [
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0
] |
NCT02286687 | 15:23:cancer,27:44:cancer,67:83:treatment | Patients with advanced or metastatic cancer that is refractory to standard therapy or has relapsed after standard therapy | 3 | [
"Patients",
"with",
"advanced",
"or",
"metastatic",
"cancer",
"that",
"is",
"refractory",
"to",
"standard",
"therapy",
"or",
"has",
"relapsed",
"after",
"standard",
"therapy"
] | [
0,
0,
3,
0,
3,
3,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT02506192 | 5:27:chronic_disease,29:31:chronic_disease,36:55:chronic_disease,57:68:chronic_disease,70:83:chronic_disease | Has Inflammatory Arthritis (RA, or Psoriatic Arthritis, Spondylitis, Polyarthritis) | 3 | [
"Has",
"Inflammatory",
"Arthritis",
"(",
"RA",
",",
"or",
"Psoriatic",
"Arthritis",
",",
"Spondylitis",
",",
"Polyarthritis",
")"
] | [
0,
2,
2,
0,
2,
0,
0,
2,
2,
0,
2,
0,
2,
0
] |
NCT01793519 | 38:49:chronic_disease,87:96:treatment,101:120:chronic_disease,136:167:treatment | Absence of documentation of negative hepatitis B serologies, absence of completion of treatment for chronic hepatitis B, or absence of suppressive antiviral treatment | 3 | [
"Absence",
"of",
"documentation",
"of",
"negative",
"hepatitis",
"B",
"serologies",
",",
"absence",
"of",
"completion",
"of",
"treatment",
"for",
"chronic",
"hepatitis",
"B",
",",
"or",
"absence",
"of",
"suppressive",
"antiviral",
"treatment"
] | [
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
1,
0,
2,
2,
2,
0,
0,
0,
0,
1,
1,
1
] |
NCT01175044 | 31:63:treatment | Patients scheduled to undergo revision total knee arthroplasty for infectious reasons | 3 | [
"Patients",
"scheduled",
"to",
"undergo",
"revision",
"total",
"knee",
"arthroplasty",
"for",
"infectious",
"reasons"
] | [
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0
] |
NCT02050113 | 1:30:chronic_disease,, | Aortic or aortoiliac aneurysm with diameter ≥5.5 cm | 3 | [
"Aortic",
"or",
"aortoiliac",
"aneurysm",
"with",
"diameter",
"≥5.5",
"cm"
] | [
2,
2,
2,
2,
0,
0,
0,
0
] |
NCT02351544 | ,,57:77:treatment | Patients who have failed 2 of 3 classes of preventative migraine medications | 3 | [
"Patients",
"who",
"have",
"failed",
"2",
"of",
"3",
"classes",
"of",
"preventative",
"migraine",
"medications"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT01128816 | 14:25:treatment,29:40:treatment,44:70:treatment | Hypertrophic obstructive or restrictive or post partum cardiomyopathy | 3 | [
"Hypertrophic",
"obstructive",
"or",
"restrictive",
"or",
"post",
"partum",
"cardiomyopathy"
] | [
0,
1,
0,
1,
0,
1,
1,
1
] |
NCT02053246 | 18:47:treatment,49:58:treatment,60:70:treatment,75:84:treatment | Current use of a third generation beta-blocker (nebivolol, carvedilol, or labetalol) | 3 | [
"Current",
"use",
"of",
"a",
"third",
"generation",
"beta-blocker",
"(",
"nebivolol",
",",
"carvedilol",
",",
"or",
"labetalol",
")"
] | [
0,
0,
0,
0,
1,
1,
1,
0,
1,
0,
1,
0,
0,
1,
0
] |
NCT02520791 | 16:24:treatment,,,,,,,,, | The effects of MEDI-570 on the developing human fetus are unknown; for this reason, women of child-bearing potential and men must agree to use adequate contraception (hormonal or barrier method of birth control; abstinence) prior to study entry, during the study participation, and for 3 months after the last dose of th... | 3 | [
"The",
"effects",
"of",
"MEDI-570",
"on",
"the",
"developing",
"human",
"fetus",
"are",
"unknown",
";",
"for",
"this",
"reason",
",",
"women",
"of",
"child-bearing",
"potential",
"and",
"men",
"must",
"agree",
"to",
"use",
"adequate",
"contraception",
"(",
"... | [
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0... |
NCT02496208 | 1:18:chronic_disease | Abdominal fistula | 3 | [
"Abdominal",
"fistula"
] | [
2,
2
] |
NCT01773707 | 41:45:treatment, | 30, 60, 90 minute plasma glucose during OGTT ≥ 200 mg/dL (11.1 mmol/L) | 3 | [
"30",
",",
"60",
",",
"90",
"minute",
"plasma",
"glucose",
"during",
"OGTT",
"≥",
"200",
"mg/dL",
"(",
"11.1",
"mmol/L",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02070549 | 1:54:treatment,63:74:treatment,76:85:treatment,87:96:treatment,144:158:treatment | multikinase antiangiogenic tyrosine kinase inhibitors such as regorafenib, sorafenib, sunitinib, etc. whose primary mechanism of action is not RAF inhibition | 3 | [
"multikinase",
"antiangiogenic",
"tyrosine",
"kinase",
"inhibitors",
"such",
"as",
"regorafenib",
",",
"sorafenib",
",",
"sunitinib",
",",
"etc",
".",
"whose",
"primary",
"mechanism",
"of",
"action",
"is",
"not",
"RAF",
"inhibition"
] | [
1,
1,
1,
1,
1,
0,
0,
1,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.